We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.97%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$717M
AUM Growth
+$489M
(+215%)
Cap. Flow
+$466M
Cap. Flow
% of AUM
65.08%
Top 10 Holdings %
Top 10 Hldgs %
52.06%
Holding
403
New
201
Increased
23
Reduced
26
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$56.1M |
| 2 |
Vanguard Total Bond Market
BND
|
+$55.9M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$52M |
| 4 |
SPDR Gold Trust
GLD
|
+$51.6M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$45.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Grupo Cibest SA
CIB
|
+$4.92M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$3.16M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$3.13M |
| 4 |
Ecopetrol
EC
|
+$3.01M |
| 5 |
NXP Semiconductors
NXPI
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.27% |
| 2 | Healthcare | 5.27% |
| 3 | Industrials | 4.04% |
| 4 | Financials | 2.18% |
| 5 | Real Estate | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Chevron
CVX
$381B
| $1.63M | 0.23% |
+17,080
| New | +$1.49M |
|
|
EPRS
77
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $1.63M | 0.23% |
604,500
+569,500
| +1,627% | +$1.6M |
|
78
PPG Industries
PPG
$25.8B
| $1.48M | 0.21% |
+13,311
| New | +$1.31M |
|
79
Wells Fargo
WFC
$266B
| $1.48M | 0.21% |
+30,521
| New | +$1.49M |
|
|
RAI
80
DELISTED
Reynolds American Inc
RAI
| $1.46M | 0.2% |
+29,106
| New | +$1.43M |
|
81
Vanguard Communication Services ETF
VOX
$5.77B
| $1.45M | 0.2% |
+15,627
| New | +$1.34M |
|
|
82
Ecopetrol
EC
$34B
| $1.41M | 0.2% |
147,700
-427,300
| -74% | -$3.01M |
|
|
AERI
83
DELISTED
Aerie Pharmaceuticals
AERI
| $1.37M | 0.19% |
113,000
+93,000
| +465% | +$1.47M |
|
84
iShares US Real Estate ETF
IYR
$4.53B
| $1.36M | 0.19% |
+17,491
| New | +$1.27M |
|
85
UnitedHealth
UNH
$396B
| $1.31M | 0.18% |
+10,130
| New | +$1.2M |
|
86
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
| $1.29M | 0.18% |
+61,935
| New | +$1.16M |
|
|
87
Alphabet (Google) Class A
GOOGL
$4.24T
| $1.26M | 0.18% |
33,100
-85,900
| -72% | -$3.16M |
|
88
Accenture
ACN
$86.2B
| $1.26M | 0.18% |
10,922
-878
| -7% | -$90.2K |
|
|
NDRM
89
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $1.22M | 0.17% |
+86,500
| New | +$1.17M |
|
90
State Street Blackstone Senior Loan ETF
SRLN
$5.32B
| $1.21M | 0.17% |
+26,125
| New | +$1.2M |
|
|
RPAI
91
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $1.21M | 0.17% |
+76,000
| New | +$1.15M |
|
|
ONCE
92
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.2M | 0.17% |
+40,600
| New | +$1.28M |
|
93
Humana
HUM
$47.8B
| $1.19M | 0.17% |
+6,518
| New | +$1.13M |
|
|
94
Alphabet (Google) Class C
GOOG
$4.22T
| $1.19M | 0.17% |
31,980
-87,340
| -73% | -$3.13M |
|
95
Bristol-Myers Squibb
BMY
$124B
| $1.19M | 0.17% |
+18,598
| New | +$1.17M |
|
|
NBSE
96
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $1.17M | 0.16% |
+913
| New | +$1.3M |
|
|
DFS
97
DELISTED
Discover Financial Services
DFS
| $1.15M | 0.16% |
+22,494
| New | +$1.08M |
|
98
Guidewire Software
GWRE
$11.9B
| $1.13M | 0.16% |
+20,749
| New | +$1.08M |
|
|
PGRE
99
DELISTED
Paramount Group
PGRE
| $1.12M | 0.16% |
+70,000
| New | +$1.12M |
|
100
NetEase
NTES
$82.9B
| $1.06M | 0.15% |
37,500
-85,000
| -69% | -$2.55M |
|
Similar funds
EC
SFM
NHC
EQF
CCM
NEI
Bailard's Q1 2016 Portfolio in Review
As of Q1 2016, Bailard held 403 positions worth $717M, up 215% from $227M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Bailard deployed $466M of net new capital in Q1 2016, opening 201 new positions and adding to 23 existing holdings. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 661,123 shares worth $56.2M.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 36% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Grupo Cibest SA, an estimated $4.92M trimmed.
- Bailard's largest Q1 2016 buy was iShares 1-3 Year Treasury Bond ETF: 661,123 shares worth $56.2M.
- Bailard added most to Teva Pharmaceuticals in Q1 2016, an estimated $3.83M increase.
- Bailard's biggest Q1 2016 reduction was Grupo Cibest SA, cutting an estimated $4.92M.
- Bailard fully exited NXP Semiconductors in Q1 2016, selling an estimated $2.76M.
- Bailard's ten largest holdings make up 52% of its $717M portfolio in Q1 2016.
- Bailard opened 201 new positions and closed 153 in Q1 2016.
- Bailard's portfolio value rose 215% quarter-over-quarter to $717M.
Based on Bailard's 13F filing for Q1 2016, filed 16 May 2016.